End Use API: CAS 6306-52-1

Louis Pharmaceuticals was born of a vision. Founded in 2009. Mr.K.Kumar, Head operations and Business development.is post graduate in Chemistry (M.Sc) and Water and environmental technologies (M.Tech) with rich experience in R&D and Production filed in various Bulk Drugs/API’s and chemical Industries. This is the dream that drives us at Louis Pharmaceuticals. The laudable goal that we aim for. The vision that suffuses us with the passion to innovate and excel. Over the past eight years seven months, we have been ceaselessly engaged in a quest to sustain and improve the quality of life through creating safe pharmaceutical solutions. Our competencies have grown to embrace the entire pharmaceutical value chain - APIs, Intermediates.

A WHO GMP ,ISO 9001-2008 and ISO 14000:2004 certified company, Shodhana Laboratories is considered to be one of the most dynamic Active Pharmaceutical Ingredients and Intermediates manufacturing companies. Today, we have the technically most advanced production facilities and our entire manufacturing process is as per ICH & cGMP guidelines. We also have a world class R&D lab manned by a dynamic team of highly qualified and experienced scientists. Our motto is to achieve Total Customer Satisfaction. Our endeavor is to continuously offer effective and reliable products at most competitive prices within scheduled time frame. Support the Customers (Pre Sale & Post Sale) with necessary documentation. Shodhana Laboratories was established in September 2000 by a technocrat entrepreneur with a Doctorate in Chemistry. After gaining 20 years of rich industrial experience in various blue chip organizations that include Standard Organics, Cheminor Drugs, (Dr. Reddy's) from its inception in 1984 till 2000 as Sr. Vice President (Technical and Bulk Operations). The Company is supported by a well experienced technical staff in Research and Development and Manufacturing.

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.